HIGHLIGHTS
- who: Jean El-Cheikh from the Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon have published the research: Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome, in the Journal: (JOURNAL)
- what: This study shows that although a shorter duration of venetoclax exposure in ND AML patients might not lead to complete toxicity control, it will lead to a more acceptable toxicity profile while maintaining efficacy . The analysis showed that patients who received venetoclax for a shorter duration, less than . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.